Urology Practice泌尿外科实践
Urology Practice(英文缩写 UROL PRACT),ISSN 2352-0779,eISSN 2352-0787,中文译名:泌尿外科实践 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-10-01 至 2026-09-30，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 未收录 | N/A |
| 2022 | 0.800 | N/A |
| 2023 | 0.800 | Q4 |
| 2024 | 1.700 | Q3 |
| 2025 | 1.600 | Q3 |
Urology Practice 最新收录文献
-
1. Utility of Men's Health Trained General Practitioners in a Urologic Men's Health Clinic.
PMID:日期:2026-09-25该文献暂无摘要。
-
4. PATIENT SATISFACTION FOLLOWING UROLOGY RETURN VISITS BASED ON PROVIDER TYPE.
PMID:日期:2026-09-24We aimed to evaluate patient satisfaction with Urology return visits between Advanced Practice Providers (APP) and Physicians in a tertiary Urology practice. Outpatient Urology visits between January 2023 to June 2024 were obtained from electronic medical records. Patients who completed a Press Ganey Patient Satisfaction Survey after return visits were identified. Return visits were conducted either by a physician or APP. The objective was to evaluate the Topbox score defined by the percentage of patients who selected "Very Good" for each survey question. Chi-square tests were utilized to compare the differences for both provider types. A total of 2522 patients completed the survey, including 1060 patients who saw a physician and 1462 patients who saw an APP. There was no significant difference in patient satisfaction as both cohorts received similar ratings for each question. This included the rating of overall care received (93.7% vs. 93.2%; p=0.64), concern the provider showed for questions/worries (92.3% vs 92.8%; p=0.66), explanation the provider gave about the condition/problem (92.4% vs 93.6%; p=0.26), and discussion of proposed treatment (92.3% vs 91.6%; p=0.54) for physicians and APPs respectively.Additional ratings included the friendless/courtesy of the provider (95.0% vs 95.5%; p=0.68), confidence level (95.2% vs 94.1%; p=0.31), ability for the provider to use words that the patient could understand (94.2% vs 93.9%; p=0.79), and instructions given about follow up care (91.7% vs 92.3%; p=0.67). There is no difference in Press Ganey patient satisfaction scores between physicians and APPs with regards to Urology return visits.
-
8. Trends in Pediatric Urology Resident Operative Exposure and Autonomy: An 11-Year National Study.
PMID:日期:2026-09-18Fewer urology residents are pursuing pediatric urology fellowship. Studies have examined potential associations between surgical residents' operative experience, autonomy, and exposure and fellowship pursuit. This relationship has not been examined with respect to pediatric urology. Furthermore, no study has characterized national trends in pediatric urology operative exposure and autonomy. We analyzed how pediatric urology case log volume and autonomy has changed over time for urology residents. A retrospective, national cohort study was completed utilizing Accreditation Council for Graduate Medical Education (ACGME) urology case log data. Variables analyzed included case category (major vs. minor), operative role, and autonomy score. ANOVA was performed to analyze differences in resident role and procedure type over time. Our study included 3,391 graduating urology chief residents from 145 ACGME accredited programs who completed training from 2013 to 2023. The mean pediatric major cases per resident by graduation declined from 72.43 (SD 35.09) in 2013 to 54.14 (SD 28.05) in 2023. Pediatric minor cases remained stable, with 127.79 (SD 62.93) cases in 2013 and 124.14 (SD 65.28) in 2023. Autonomy scores declined from 2013 to 2023 for both categories (86% to 73% for major cases; 94% to 82% for minor cases). Over time, urology residents are experiencing less operative exposure to pediatric major cases, while exposure to minor cases has remained stable. Resident autonomy during pediatric cases has decreased for both categories. Future studies should explore how decreased exposure and autonomy impacts resident confidence and preparedness, as well as the likelihood of pursuing pediatric urology fellowship.
-
9. Synchronous versus Staged Implantation of Inflatable Penile Prosthesis and Artificial Urinary Sphincter: A Nationwide Analysis of Infection and Revision Outcomes.
PMID:日期:2026-09-11The timing of implantation of inflatable penile prostheses (IPP) and artificial urinary sphincters (AUS) in patients requiring both devices remains controversial, with limited data comparing outcomes between synchronous dual implantation versus staged procedures. To assess the association between timing of IPP and AUS implantation and subsequent rates of device infection, revision, removal, or replacement using real-world administrative claims data. We performed a retrospective review using the Merative Marketscan® research databases from 2007 to 2023. Men undergoing IPP and/or AUS implantation were identified using CPT diagnosis and ICD procedure codes. Patients were stratified into four groups: synchronous dual implantation, solitary implant (IPP or AUS alone), and staged implantation (IPP or AUS first, followed by the other device). The primary composite outcome was device infection, revision, removal, or replacement. Patient demographics and comorbidities were collected. Kaplan-Meier survival analysis and multivariable Cox proportional hazards regression models were used to compare outcomes between groups, adjusting for relevant clinical variables. We identified 18,426 men who underwent IPP placement, 4,523 men who underwent AUS placement, and 659 men receiving both implants. Of these, 357 underwent concurrent IPP and AUS implantation, while 302 were implanted in a staged fashion. There was a higher risk of infection when placing two implants compared to placing one implant (HR 1.43 (1.13-1.80), p= 0.0032). However, synchronous placement of IPP and AUS was not associated with an increased risk of reoperation compared to staged placement (HR 1.50 (95% CI 0.87-2.58), p=0.2). In the largest known cohort study of its kind, synchronous placement of IPP and AUS is not associated with higher rates of reoperation compared to staged placement, supporting the feasibility of concurrent implantation.